Skip to main content

Integrative Practitioner

Facebook-f Linkedin-in Instagram

Articles

SHARE

A 1970s Lipid-Lowering Compound May Offer a New Approach to Obesity 

September 15, 2026

Obesity can cause metabolic conditions, including abnormal blood lipid levels, insulin resistance, and diabetes. Incretin-based drugs, such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), continue to see widespread use for...

Read More

Patients with IBD Show Higher Risk of Psychiatric Disorders 

September 11, 2026

By Irene Yeh  September 11, 2026 | Evidence suggests that patients with inflammatory bowel disease (IBD), comprising Crohn’s disease (CD), ulcerative colitis (UC), and IBD-unclassified (IBD-U), may be more susceptible...

Read More